Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 970

Results For "CE"

11067 News Found

X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery
News | March 30, 2022

X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery

Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems


Govt clears 49 applicants for PLI in Bulk Drugs
News | March 30, 2022

Govt clears 49 applicants for PLI in Bulk Drugs

The selected 49 applications are from 33 companies. Out of these 33 companies, 13 are Micro, Small and Medium Enterprises (MSMEs) besides some newly incorporated entities


Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies
Public Health | March 30, 2022

Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies

India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.


OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


Dysval gets regulatory approval in Japan
Drug Approval | March 29, 2022

Dysval gets regulatory approval in Japan

Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients


Carestream Health India showcases two new products at IRIA
Medical Device | March 29, 2022

Carestream Health India showcases two new products at IRIA

As a partner with IRIA, the company had a significant booth presence on-ground during the conference.


Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad
Digitisation | March 29, 2022

Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad

The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development


Solvay partners with Mitsubishi Chemical to recycle end-of-life medical components
News | March 29, 2022

Solvay partners with Mitsubishi Chemical to recycle end-of-life medical components

New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.


Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Drug Approval | March 29, 2022

Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes

Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults